echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > British researchers have developed new technology for testing drug resistance

    British researchers have developed new technology for testing drug resistance

    • Last Update: 2007-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Zui, a British researcher, has developed a new technology to detect drug resistance, which can directly use cultured human cells to detect drug safety without using active substances The basic operation of the new technology developed by researchers at University of Manchester, UK, is to test the properties of cultured human cells This method can also detect the carcinogenic compounds in drugs more effectively This method is very sensitive and can identify most carcinogens However, some chemicals known as "pre mutagens" are carcinogens only when they pass through the human liver, so animal tests are still needed to determine such substances.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.